|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
FY2020
12 months to Jan 2, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Total net revenues | |||||
| Cost of net revenues | |||||
| Total cost of net revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Asset impairments and restructuring | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Other income (expense), net | |||||
| Loss from continuing operations before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss from continuing operations | |||||
| Loss from Photonics division, net of tax | |||||
| Gain on sale of Photonics division, net of tax | |||||
| Income from discontinued operations, net of tax | |||||
| Net loss | |||||
| Net income (loss) per share: | |||||
| Basic—continuing operations | |||||
| Diluted—continuing operations | |||||
| Basic—discontinued operations | |||||
| Diluted—discontinued operations | |||||
| Basic—net loss | |||||
| Diluted—net loss | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...